Live Quote · NASDAQHROWHealthcare· Drug Manufacturers - Specialty & Generic

Harrow Health, Inc.

$30.41▼ 5.35%($-1.72)
MKT CAP $1.14BNEXT EARNINGS Mar 1, 2027
50%
Bullish
TickerSpark Score
62/100
▌ Mixed
56
Valuation
40
Profitability
100
Growth
64
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HROW research report →

Analyst Price Target
$45.00+48.0% vs. today

Range $45 – $45

Analyst RatingBuy
10 Buy0 Hold0 Sell

Price Chart

-13.89% · this period
$54.80$40.42$26.04Nov 20May 26Nov 20
52-Week Range16% of range
Low
$25.76
Current
$30.41
High
$54.85